Operational, Management and Research Staff
PHIGENIX Founder & President/CEO
Dr. Carlton D. Donald founded Phigenix in 2007. He is a molecular biologist and clinical research scientist with over 25 years of experience in cancer research. To date, Dr. Donald has approximately 100 patents, pending patents, and applications in the area of oncology, and has authored a number of ground-breaking articles on cancer initiation and progression as well as tumor immunity. Dr. Donald continues to provide his scientific expertise in the research and development of Phigenix's diagnostics and therapeutics. He also serves as the Chairman of the Board of Directors.
PHIGENIX Board of Directors and Advisors
Mrs. Wennifer H. Donald, Director & Vice-president/COO: Mrs. Donald has over 20 years of experience in business management. She has served as an corporate executive at the national headquarters of a Fortune 500 financial institution in Atlanta, Georgia. In addition, she has also served as lead operations manager for a multi-million dollar firm located in Atlanta, Georgia.
Dr. J. Page Brown, Director & Head of Research and Development: Dr. Brown is a pharmaceutical veteran with substantial experience in product development and project management including serving as a lead scientist and biochemist for several fortune 100 firms such as Procter & Gamble and Kimberly Clark.
Dr. Charles A. West, Director and Head of Business Development: Dr. West is a catalyst for economic optimization. He leveraged myriad educational, training, business consulting and research experiences into successful entrepreneurial and non profit endeavors. Dr. West led the first minority teams to buy, manage and sell four major national franchise concepts. Later he served as Senior Consultant and Chief Operating Officer for a Kauffman Foundation spinoff and Founding Director of ThinkShift, Inc. , now The DeBruce Foundation.
Mr. Scott Cha-Choe, Director: Mr. Cha-Choe is currently EVP & COO for an Atlanta based investment consulting firm advising institutional clients-pension funds, foundations and endowments. He has served on various boards and has been on advisory roles with startup companies utilizing his experience in strategic planning and business development.
Dr. Richard A. Roy, Lead Medical Advisor: Dr. Roy is a Board Certified Urologist and clinical scientist. He currently operates a urological practice in Columbus, OH, which consists of 30 urologists and a pathology diagnostic laboratory for urological cancers.
Investors
Updates Coming Soon!!!